Evidence map›Paper›PMID 33874776›Full record

ArticleThe Journal of international medical research2021

Primary central nervous system Hodgkin's lymphoma: a case report.

Haiying Fu, Songsheng Shi, Lusan Chen, Benhua Xu, Wanling Huang, Yi Chen, Xuejing Wu, Jianzhen Shen, Tingbo Liu

Open access · goldAbstract readCase Reports
In one paragraph

Article in The Journal of international medical research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Haiying FuDepartment of Haematology, Fujian Medical University Union Hospital, Fujian Institute of Haematology, Fujian Medical Centre of Haematology, Fujian Provincial Key Laboratory on Haematology, Fuzhou, Fujian Province, China.ORCID https://orcid.org/0000-0001-8695-2640
Songsheng ShiDepartment of Neurosurgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China.
Lusan ChenDepartment of Pathology, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China.
Benhua XuDepartment of Radiotherapy, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China.
Wanling HuangDepartment of Haematology, Fujian Medical University Union Hospital, Fujian Institute of Haematology, Fujian Medical Centre of Haematology, Fujian Provincial Key Laboratory on Haematology, Fuzhou, Fujian Province, China.
Yi ChenDepartment of Haematology, Fujian Medical University Union Hospital, Fujian Institute of Haematology, Fujian Medical Centre of Haematology, Fujian Provincial Key Laboratory on Haematology, Fuzhou, Fujian Province, China.
Xuejing WuDepartment of Pathology, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China.
Jianzhen ShenDepartment of Haematology, Fujian Medical University Union Hospital, Fujian Institute of Haematology, Fujian Medical Centre of Haematology, Fujian Provincial Key Laboratory on Haematology, Fuzhou, Fujian Province, China.
Tingbo LiuDepartment of Haematology, Fujian Medical University Union Hospital, Fujian Institute of Haematology, Fujian Medical Centre of Haematology, Fujian Provincial Key Laboratory on Haematology, Fuzhou, Fujian Province, China.
Fujian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary central nervous system Hodgkin's lymphoma (CNS-HL) is extremely rare. This current case report describes a 60-year-old male patient that presented with numbness of the left lower extremity and worsening headache. After a full range of investigations and a partial resection of the right cerebellum, external ventricular drainage reservoir placement and cranioplasty, he was diagnosed with primary CNS-HL. The patient was treated with 3 g/m

Indexed as

Central Nervous System NeoplasmsHodgkin DiseaseAntineoplastic Combined Chemotherapy ProtocolsCentral Nervous SystemCytarabineHumansMaleMethotrexateMiddle AgedNeoplasm Recurrence, LocalCytarabineMethotrexateHodgkin's lymphomaPrimary central nervous systemprognosisprogrammed cell death-1treatment

Identifiers

PMID33874776
PMCPMC8060762
OpenAlexW3156238961

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.